Among posterior circulation arteries, the intracranial vertebral artery (ICVA) has been given the least attention, especially concerning treatment of occlusive lesions. Early clinicopathological studies showed that the ICVA was often occluded in patients with lateral medullary and posterior inferior cerebellar infarcts. Severe stenosis or occlusion of the ICVA was the most common arterial lesion among the 408 patients in the New England Medical Center Posterior Circulation Registry (NEMC-PCR). In this registry, the distal portion of the artery was most often involved, sometimes with spread into the basilar artery. ICVA occlusive lesions were often bilateral and very often accompanied by basilar and cervical vertebral artery occlusive lesions. Patients with bilateral ICVA occlusions often had attacks of dizziness, blurred vision, and ataxia during months and years but rarely later developed disabling infarction. Most posterior circulation infarcts in patients with ICVA occlusive lesions were located in the middle and distal posterior circulation territories and were rostral to the medulla and inferior cerebellum. Although diagnostic techniques now image the ICVA and its lesions well, the optimal treatment of patients with various ICVA occlusive lesions has very rarely been analyzed or reported. The therapeutics of patients with ICVA disease is uncharted territory and begs for attention and clarification.

Keywords:
Vertebral artery, Medullary infarction, Cerebellar infarction
1.
Wepfer, Johan Jacob: Observationes anatomicae ex cadaveribus eorum, quos sustulit apoplexia, cum exercitatione de ejus loco affecto. J Caspari Suteri, Schaffhausen, 1658.
2.
Clarke E, O’Malley CD: The Human Brain and Spinal Cord. A Historical Study. Berkeley, University of California Press, 1968, pp 774–775.
3.
Wolf M: Wallenberg’s syndrome; in Wolf M (ed): The Classical Brain Stem Syndromes. Springfield, Thomas, 1971, pp 113–136.
4.
Wallenberg A: Acute Bulbaraffection (Embolie der Art. cerebellar post. inf. sinistra?). Arch Psychiatr Nervenkr 1895;27:504–540.
5.
Wallenberg A: Anatomischer Befund in einem als ‘acute Bulbaraffection (Embolie der Art. cerebellar post. inf. sinistra?)’ beschriebenen Falle. Arch Psychiatr Nervenkr 1901;34:923–959.
6.
Duvernoy HM: Human Brainstem Vessels, ed 2. Berlin, Springer, 1999.
7.
Fisher CM, Karnes W, Kubik CS: Lateral medullary infarction. The pattern of vascular occlusion. J Neuropath Exp Neurol 1961;20:323–379.
8.
Hauw J-J, Der Agopian P, Trelles R, Escourolle R: Les infarctus bulbaires. Etude systématique de la topographie lésionelle dans 49 cas. J Neurol Sci 1976;28:83–102.
9.
Escourolle R, Hauw JJ, Der Agopian P, Trelles L: Les infarctus bulbaires. Etude des lésions vasculaires dans 26 observations. J Neurol Sci 1976;28:103–113.
10.
Ogata J, Masuda J, Yutani C, Yamaguchi T: Mechanisms of cerebral artery thrombosis: a histopathological analysis on eight necropsy cases. J Neurol Neurosurg Psychiatry 1994;57:17–21.
11.
Kim JS: Medullary infarcts and hemorrhages; in Caplan LR, Van Gijn J (eds): Stroke Syndromes, ed 3. Cambridge, Cambridge University Press, 2012.
12.
Sypert GW, Alvord EC: Cerebellar infarction: a clinicopathological study. Arch Neurol 1975;32:357–363.
13.
Schwartz CJ, Mitchell JRA: Atheroma of the carotid and vertebral arterial systems. Br Med J 1961;ii:1057–1063.
14.
Fisher CM, Gore I, Okabe N, White PD: Atherosclerosis of the carotid and vertebral arteries – extracranial and intracranial. J Neuropathol Exp Neurol 1965;24:455–476.
15.
Moosy J: Morphology, sites, and epidemiology of cerebral atherosclerosis in research publications. Assoc Res Nerv Ment Dis 1966;51:1–22.
16.
Castaigne P, Lhermitte F, Gautier JC, et al: Arterial occlusions in the vertebro-basilar system. A study of 44 patients with post-mortem data. Brain 1973;96:133–154.
17.
Caplan LR, Baquis GD, Pessin MS, D’Alton J, Adelman LS, DeWitt LD Ho K, Izukawa D, Kwan ES: Dissection of the intracranial vertebral artery. Neurology 1988;38:868–877.
18.
Estol C, Caplan LR: Intracranial dissections; in Caplan LR, Van Gijn J (eds): Stroke Syndromes, ed 3. Cambridge, Cambridge University Press, 2012.
19.
Escourolle R, Gautier J-C, Rosa A, der Agopian P, Lhermitte F: Aneurysme disséquant vertébro-basilaire. Rev Neurol 1972;128:95–104.
20.
Koroshetz WJ, Ropper AH: Artery-to-artery embolism causing stroke in the posterior circulation. Neurology 1987;37:292–296.
21.
Caplan LR, Rosenbaum A: The role of cerebral angiography in vertebro-basilar occlusive disease. J Neurol Neurosurg Psychiatry 1975;38:601–612.
22.
Caplan LR: Posterior Circulation Disease. Clinical Findings, Diagnosis, and Treatment. Boston, Blackwell Science, 1996.
23.
Caplan LR, Wityk RJ, Glass TA, et al: New England Medical Center Posterior Circulation Registry. Ann Neurol 2004;56:389–398.
24.
Savitz S, Caplan LR: Vertebrobasilar disease. N Engl J Med 2005;352:2618–2626.
25.
Caplan LR, Chung CS, Wityk RJ, et al: New England Medical Center Posterior Circulation Stroke Registry. I. Methods, database, distribution of brain lesions, stroke mechanisms and outcomes. J Clin Neurol 2005;1:14–30.
26.
Caplan LR, Wityk RJ, Pazdera L, Chang HM, Pessin MS, Dewitt LD: New England Medical Center Posterior Circulation Stroke Registry. II. Vascular Lesions. J Clin Neurol 2005;1:31–49.
27.
Glass TA, Hennessey PM, Pazdera L, et al: Outcome at 30 days in the New England Medical Center Posterior Circulation Registry. Arch Neurol 2002;59:369–376.
28.
Graf KJ, Pessin MS, DeWitt LD, Caplan LR: Proximal intracranial territory posterior circulation infarcts in the New England Medical Center Posterior Circulation Registry. Eur Neurol 1997;37:157–168.
29.
Muller-Kuppers M, Graf KJ, Pessin MS, DeWitt LD, Caplan LR: Intracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Eur Neurol 1997;37:146–156.
30.
Shin HK, Yoo KM, Chang HM, Caplan LR: Bilateral intracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1999;56:1353–1358.
31.
Feldmann E, Wilterdink JL, Kosinski A, et al, for the Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis Trial Investigators: The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trial. Neurology 2007;68:2099–2106.
32.
Tsivgoulis G, Sharma VK, Hoover SL, et al: Applications and advantages of power motion-mode Doppler in acute posterior circulation cerebral ischemia. Stroke 2008;39:1197–1204.
33.
Bash S, Villablanca JP, Duckwiler G, Tillis M, Kidwell C: Intracranial vascular stenosis and occlusive disease. Evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol 2005;26:1012–1021.
34.
European Stroke Prevention Study Group: European Stroke Prevention Study: principal end-points. Lancet 1987;ii1351–1354.
35.
Sivenius J, Riekkinen PJ, Smets P, Laakso M, Lowenthal A: The European Stroke Prevention Study (ESPS): results by arterial distribution. Ann Neurol 1991;29:596–600.
36.
Chimowitz M, Kokkinos ChB, Strong J, et al, for the Warfarin-Aspirin Symptomatic Intracranial Disease Study Group: The warfarin-aspirin symptomatic intracranial disease study. Neurology 1995;45:1488–1493.
37.
Chimowitz MI, Lynn MJ, Howlett-Smith H, et al, for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–1316.
38.
Kasner SE, Lynn MJ, Chimowitz MI, et al, for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators: Warfarin vs. aspirin for symptomatic intracranial stenosis: subgroup analysis of WASID. Neurology 2006;67:1275–1278.
39.
Becker KJ, Monsein LH, Ulatowski J, Williams M, Hanley DF: Intraarterial thrombolysis in vertebro basilar occlusion. AJNR Am J Neuroradiol 1996;17:255–262.
40.
Nakayama T, Tanaka K, Kaneko M, Yokoyama T, Uemura K: Thrombolysis and angioplasty for acute occlusion of intracranial vertebrobasilar arteries. J Neurosurg 1998;88:919–922.
41.
Wang Bin, Wang Yabing, Li Shenmao, et al: Intra-arterial thrombolysis combined with angioplasty for treatment of acute ischemic cerebral infarction. Chin J Cerebrovasc Dis 2011;8:65–69.
42.
Takis C, Kwan E, Pessin MS, Jacobs D, Caplan LR: Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997;18:1661–1668.
43.
Chimowitz MI, Lynn MJ, Derdeyn CP, et al, for the SAMPRIS Investigators: Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003.
44.
Searls DE, Pazdera L, Korbel E, Vysata O, Caplan LR. Symptoms and signs of posterior circulation ischemia in the New England Medical Center Posterior Circulation Registry. Arch Neurol 2012;69:346–351.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.